29.4.2003 Official Journal of the European Union L 106/35 (Acts whose publication is not obligatory) COMMISSION COMMISSION DECISION of 28 April 2003 appointing members of the Committee for Orphan Medicinal Products (Text with EEA relevance) (2003/296EC) THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products (), and in particular Article 4(3) thereof, Whereas: (1)  The term of office of the members of the Committee for Orphan Medicinal Products, hereinafter ‘the Committee’ set up in accordance with Article 4 of Regulation (EC) No 141/2000 expires on 15 April 2003. It is necessary, therefore, to appoint a new member and to renew the terms of office of certain existing members. (2)  The European Agency for the Evaluation of Medicinal Products has recommended three persons for nomina- tion. (3)  The members of the Committee should be appointed for a period of three years starting on 16 April 2003, HAS DECIDED AS FOLLOWS: Article 1 1. The following is hereby appointed member of the Committee for Orphan Medicinal Products, hereinafter referred to as ‘the Committee’, to represent patients' organisations for a term of three years, from 16 April 2003: Birthe Holm. 2. The following are hereby reappointed members of the Committee to represent patients' organisations for a term of three years, from 16 April 2003: Yann Le Cam Alastair Kent. Atticle 2 On the recommendation of the European Agency for the Evaluation of Medicinal Products, the following are hereby reappointed members of the Committee for a term of three years, from 16 April 2003: Dr Eric Abadie Dr David Lyons Prof. Gianmartino Benzi. Done at Brussels, 28 April 2003. For the Commission Erkki LIIKANEN Member of the Commission () OJ L 18, 22.1.2000, p. 1.